2013 Revenue: $1 billion
HQ: Carros, France
Founded in 1968 by a French veterinarian, the private company based out of Carros, near Nice, came in as the 8th largest animal health company last year. The company only produces animal health products, focusing on vaccines and meds for both companion and production animals. Virbac has an extensive global reach: 70% of its employees work outside of France, and the company has production sites in 10 countries. Chairman Eric Maree said in last year's annual report that despite 6.9% sales growth from 2012, the company "was severely handicapped, however, by the highly unfavorable movements in exchange rates since nearly all currencies, in particular in emerging countries, worsened against the euro." It was also hurt by a recall of 34 lots of its Iverhart Plus product, which failed potency specifications--but the company began redistributing the product this month. Also this month, Virbac poached ex-Merial head Alan Taylor to spearhead its North American operations as vice president of the region's business development. Virbac's latest products include Flimabo, a deworming treatment for chicken and pigs, and CaniLeish, a parasitic vaccine for canines. -- Justin Heifetz (email | Twitter)
Virbac H1 sales hurt by Iverhart recall in U.S.